Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Remote ischemic conditioning wikipedia , lookup
Cardiac contractility modulation wikipedia , lookup
Electrocardiography wikipedia , lookup
Hypertrophic cardiomyopathy wikipedia , lookup
Coronary artery disease wikipedia , lookup
Heart arrhythmia wikipedia , lookup
Management of acute coronary syndrome wikipedia , lookup
Quantium Medical Cardiac Output wikipedia , lookup
Ventricular fibrillation wikipedia , lookup
Arrhythmogenic right ventricular dysplasia wikipedia , lookup
174 JACC Vol. 26, No. 1 July 1995:174-9 Dispersion of QT Interval in Patients With and Without Susceptibility to Ventricular Tachyarrhythmias After Previous Myocardial Infarction J U H A S. PERKIC)M,~KI, MD, M. J U H A N I K O I S T I N E N , MD, S I N I K K A Y L I - M A Y R Y , MD, H E I K K I V. H U I K U R I , MD, F A C C Oulu, Finland Objectives. The aim of this study was to estimate the value of QT dispersion measurement from the standard 12-1ead electrocardiogram (ECG) in identifying patients susceptible to reentrant ventricular tachyarrhythmias after a previous myocardial infarction. Background. Variability in QT interval duration on the different leads of the 12-lead ECG has been proposed as an indicator of risk for ventricular arrhythmias in different clinical settings, but the value of QT dispersion measurement in identifying patients at risk for reentrant ventricular tachyarrhythmias after myocardial infarction is not known. Methods. The QT interval duration, QT dispersion and clinical and angiographic variables were compared between 30 healthy subjects; 40 patients with a previous myocardial infarction but no history of arrhythmic events or inducible ventricular tachycardia during programmed electrical stimulation; and 30 postinfarction patients with a history of cardiac arrest (n = 12) or sustained ventricular tachycardia (n = 18) and inducible, sustained monomorphic ventricular tachycardia by electrical stimulation. Results. Dispersion of the corrected QT interval (QTc) differed significantly between the study groups and was significantly increased in patients with susceptibility to ventricular tachyarrhythmias ([mean -+ SD] 104 -+ 41 ms) compared with that in both healthy subjects (38 _+ 14 ms, p < 0.001) and postinfarction patients with no susceptibility to arrhythmias (65 + 31 ms, p < 0.001). Maximal QT interval duration was also prolonged in the group with arrhythmias compared with that in the other groups (p < 0.001). Multivariate analysis, including clinical and angiographic variables, QT dispersion and maximal QT interval, showed that QT dispersion was the independent factor that most effectively identified the patient groups with and without susceptibility to ventricular tachyarrhythmias (p < 0.001). Conclusions. Increased QT dispersion is related to susceptibility to reentrant ventricular tachyarrhythmias, independent of degree of left ventricular dysfunction or clinical characteristics of the patient, suggesting that the simple, noninvasive measurement of this interval from a standard 12-lead ECG makes a significant contribution to identifying patients at risk for life-threatening arrhythmias after a previous myocardial infarction. (JAm 6bll Cardiol 1995;26:174-9) Experimental studies have provided powerful evidence of the significance of the dispersion of myocardial recovery times for the occurrence of ventricular arrhythmias (1-4). However, current methods of measuring recovery time dispersion (i.e., epicardial or endocardial monophasic action potentials) and body surface mapping are not very practical for routine clinical use. Recently, measurement of the variability in QT interval duration among the different leads of the standard 12-lead electrocardiogram (ECG) (i.e., QT dispersion) has been proposed as a noninvasive method for detecting the inhomogcneity of ventricular recovery times (5-9). Previous clinical studies of QT dispersion have shown it to be increased in patients after acute myocardial infarction (8), in patients with the long QT syndrome (10) and in patients with hypertrophic cardiomyopathy (11). In the two latter patient groups, prolonged QT dispersion has also been shown to be related to an increased risk for serious ventricular arrhythmias (5,11). The mechanism of ventricular arrhythmias in patients with an old myocardial infarction is probably different from that in the other two patient groups, and, to our knowledge, there is no information on the significance of QT dispersion for susceptibility to arrhythmias in patients with a previous myocardial infarction. The present study was therefore designed to test the value of QT dispersion measurement for identifying patients at risk for life-threatening arrhythmias after a previous myocardial infarction by comparing QT dispersion between healthy subjects and two patient groups with differing susceptibilities to ventricular tachyarrhythmias. From the Division of Cardiology, Department of Medicine, University of Oulu, Oulu, Finland. ]"his study was supported by grants from the Orion Corporation Research Foundation, the Finnish Foundation for Cardiovascular Research and the Medical Council of the Academy of Finland, Helsinki, Finland. Manuscript received October 19, 1994; revised manuscript received February. 1, 1995, accepted February,' 27, 1995. Address fur correspondence: Dr. Juha S. PerkiOm~iki, Division of Cardiology, Department of Medicine, Oulu University Central Hospital, 90220, Oulu, Finland. 351995 by the American ('o[lcgc ol ('ardiolog5 Methods Patients. The study included 100 subjects: 30 healthy volunteers (control group) with no disease or medication and no 0735-1097/95/$9.50 0735-1097(95)00122-K JACC Vol. 26. No. 1 July 1995:174-9 PERKIOMJkKI ET AL. Q I DISPERSION FOR SUSCEPTIBILITY TO VT AFTER AM1 Table 1. Clinical Characteristics of the Study Patients Age (yr) Male/female Time from previous MI (mo) Medication ACE inhibitor Beta-blocker Digitalis Diuretic drugs NYHA functional class I/H/Ill Coronary angiographic CAD 1 vessel 2 vessel 3 vessel LVEF (%) Pts With MI but No VT (n 40) Pts With MI and VT (n 30) 59 + 6 3t*/I 28 + 19 62 + 8* 27/3 16 + 18 5 32 II It) 0/17/23 4 14" 9 9 1/15/12 I 17 22 47 + q 6 10 12* 43 - 11 *p < 0.05 between groups. Data presented are mean value + SD or numbcr of patients (Pts). ACE angiotensin-eonverting enzymc: CAD coronary artery disease; LVEF left ventricular ejection fraction; MI myocardial infarction: NYHA - New York Heart Association: VT vcntricular tachyarrhythmia. evidence of ischemic ST segment depression on exercise electrocardiography (mean [_+SD] age 45 + 6 years, range 35 to 59; 28 men, 2 women); 40 patients with a history of myocardial infarction but no history of nonsustained or sustained ventricular tachyarrhythmia and no inducible ventricular tachyarrhythmia during programmed electrical stimulation; and 30 patients with a history of myocardial infarction and sustained ventricular tachycardia (n = 18) or cardiac arrest (n = 12) (>3 months after a previous myocardial infarction) and inducible, sustained monomorphic ventricular tachyarrhythmia during programmed electrical stimulation. The patients without ventricular tachyarrhythmias were selected from a consecutive series of patients referred to the Oulu University Central Hospital for coronary angiography, and those with ventricular tachyarrhythmias were selected from a consecutive series of patients examined electrophysiologically because they had experienced a documented sustained ventricular tachycardia or cardiac arrest. Patients without arrhythmic events but with inducible nonsustained or sustained ventricular tachycardia were excluded from the consecutive series, as were those with inducible ventricular fibrillation or polymorphic ventricular tachycardia. All patients with a previous myocardial infarction were examined by means of cardiac catheterization, coronary angiography and programmed electrical stimulation. A 12-lead surface ECG at a paper speed of 50 rnm/s was recorded for every healthy subject and postinfarction patient, and all were in sinus rhythm. The clinical and angiographic characteristics of the patients are presented in Table 1. Informed consent for the electrophysiologic studies was obtained from the patients, and the study protocol was approved by the hospital ethics committee. Eleetrophysiologic testing. Electrophysiologic testing included programmed ventricular stimulation using up to three 175 extrastimuli and two basic drive cycle lengths (600 and 400 ms) from the right ventricular apex and outflow tract. Ventricular tachycardia was defined as 1) sustained when its duration was >30 s or if defibrillation was required for its termination; and 2) as nonsustained if it lasted >5 beats but <30 s. The electrophysiologic testing protocol and definitions of inducible arrhythmias have been previously described (12). Angiographic studies. Left-sided cardiac catheterization was performed using the Judkins technique. Selective coronary artery angiograms were obtained in multiple projections, including caudal and cranial views, and a lumen narrowing >50% was considered significant stenosis. Exercise test. The healthy subjects performed a symptomlimited, maximal, dynamic exercise test on an electrically braked bicycle ergometer, starting at a work load of 30 to 50 W that was increased by 10 to 15 W/min (13). Measurement of QT interval and dispersion. The QT and QT apex (QTa) intervals and QRS complex duration were measured at each lead of the 12-lead surface ECG for two consecutive cycles. The QT intervals were measured from the onset of the QRS complex to the end of the T wave by means of a tangential method. When U waves were present, the QT interval was measured to the nadir of the curve between the T and U waves, also with the aid of a tangential method. The OTa intervals were measured from the onset of the QRS complex to the apex of the T wave. The QRS complex duration was measured from the beginning of the QRS complex to its end. The T end-interval (Te) (from the apex of the T wave to its end) was calculated from the equation Te = QT - QTa, and the JT interval (from the J point to the end of the T wave) from the equation JT = QT QRS. The measurements were performed manually by two independent observers unaware of the patient's clinical data. The QT, QTa, JT, Te and QRS dispersions were defined as the differences between the maximal and minimal QT, QTa, JT, Te and QRS values, respectively, and the mean value of the two consecutive cycles was calculated. Bazett's formula was used to obtain rate-corrected values of the QT, QTa, JT and Te intervals and dispersions (QTc, QTac, JTc and Tec, respectively). The intraobserver and interobserver variation in the QT dispersion measurements was calculated. The measurements of the more experienced observer were used for statistical comparisons. Statistics. Kruskal-Wallis one-way analysis of variance was uscd to estimate differences in the QTc, QTac, JTc, Tec intervals, QRS duration and QTc, QTac, JTc, Tec and QRS dispersions between the three study groups. Thereafter, the standard t test was performed to estimate the significance levels between the groups. The Pearson correlation coelficient was used to estimate univariate correlations between the variables. Logistic multiple regression analysis (forward method with Wald statistics) was used to evaluate the independent values of the different variables in differentiating the patient groups with and without susceptibility to ventricular tachyarrhythmias; p < 0.05 was considered significant. 176 PERKIOMJkKI ET At.. QT DISPERSION FOR SUSCEPTIBILITY TO VT A F T E R AMI JACC Vol. 26, No. 1 July 1995:174-9 Table 2. RR Interval, QT Intervals and QT Dispersion R R interval (ms) QTc interval (ms) Max Min QTac interval (ms) Max Min 250 Healthy Subjects (n = 30) Pts With MI but No VT (n = 40) Pts With MI and VT (n = 30) 942 + 143 952 _+ 177 964 + 205 Min Tec interval (ms) 412 +_ 25 448 + 39* 493 _+ 51*t 375 + 24 383 +_ 20 388 + 30 338 _+ 22 299 + 23 367 _+ 35* 305 -+ 29 383 + 38* 296 + 33 91 + 7 127 + 16" 137 + 25" I I 200 v E 150 63 + 8 81 + 15" 89 + 20* O3 L_ U] 97 + 17 104 _+ 22 Min 61 + 11 61 + 15 134 + 28'+ 100 I o 50 70 + 15:~§ O 0 334 _+ 21 341 + 35 378 + 4 9 ' t 289 + 23 269 + 275 269 _+ 30:~ QTc 38 +- 14 65 + 31" 104 _+ 4 l * t QT 36 + 14 63 + 29* 101 +- 3 9 " t QTac QTa QRS 39 +- 20 38 + 19 28 + II f,2 + 325 60 _+ 30:~ 46 + 13" 87 -+ 37'11 48 + 16" Tec Te 36 + 17 34 2 14 43 + 20 41 _+ 18 64 + 28"1' 62 +, 28"t JTc 45 +- 14 72 + 33* 110 + 4(I*- JT 44 +, 14 70 + 32* 106 + 39*- s5 + 38"11 *p < 0.001, 5p < 0.01 between patients without ventricular tachycardia (VT) and healthy subjects and between patients with ventricular tachycardia and healthy subjects, t p < 0.001, §p < 0.05, lip < 0.01 between patients with and without ventricular tachycardia. Data presented are mean value _+ SD. JTc, QTac, QTc, Tec - rate-corrected JT. QTa, QT and Te intervals, respectively; QTa - QT apex interval; Max - maximum; Min minimum; Te = T end-interval (from apex of T wave to its end); other abbreviations as in l~able 1. Results Clinical and angiographic data (Table 1). Patients with arrhythmias were somewhat older than those without arrhythmias ([mean _+ SD] 62 _+ 8 vs. 59 _+ 6 years, p < 0.05), and patients without tachyarrhythmias more frequently had multivessel coronary artery disease than those with arrhythmias. There were no significant differences in time from the previous myocardial infarction or in left ventricular ejection fraction between the patient groups. Beta-adrenergic blocking agents were more commonly used by patients without than with tachyarrhythmias. QT interval, QRS duration, RR interval. The maximal QTc interval differed significantly between the three groups (p < 0.001) and was longest in the ventricular tachyarrhythmia group (Table 2). Both patient groups had a significantly longer maximal QTac interval and maximal and minimal QRS duration (p < 0.001) and a shorter minimal JTc interval (p = 0.002) than did the control group. Maximal and minimal Tec and maximal JTc intervals were longer in the group with ventricular tachyarrhythmia than in the other groups. Minimal QTc and ¥ J JTc interval (ms) Min Dispersion (ms) I E O Max Max 1 (2 QRS duration (ms) Max I I -p<O.O01- -p<O.O01 0 healthy ' MI+, VT- ' MI+, VT+ subjects Figure 1. QTc dispersion in the three study groups. Vertical bars represent 95% confidence intervals of mean values. MI = myocardial infarction; VT = ventricular tachyarrhythmia; + (-) = presence (absence). QTac intervals did not differ significantly, and average heart rate was similar among the three study groups. QT dispersions. QTc, JTc and QTac dispersions differed significantly between the three groups and were broadest in the group with ventricular tachyarrhythmia and narrowest in the control group (p < 0.001) (Table 2, Fig. 1). Patients with ventricular tachyarrhythmias had a longer Tec dispersion than patients without arrhythmias and healthy subjects. QRS dispersion was broader in both patient groups than in the control group (p < 0.001) but did not differ significantly between the two patient groups. Multiple regression analysis. Because the patient groups differed with regard to age and use of beta-blockers as well as severity of angiographic coronary artery disease, univariate analyses were first performed to assess the possible effects of these variables on QTc dispersion. Age had no significant correlation with QTc dispersion in either the control group (r -- 0.08, p = 0.7) or the patient groups (r = 0.19, p = 0.3), nor did QTc dispersion differ between patients with (77 -+ 41 ms) or without beta-blockers (82 _+ 31 ms, p = 0.5). QTc dispersion was also unrelated to left ventricular ejection fraction (r = -0.13, p = 0.3) or angiographic severity of the coronary artery disease. Logistic multiple regression analysis between patients with and without tachyarrhythmias, including QTc dispersion, maximal QTc interval, age, left ventricular ejection fraction and use of beta-blockers as covariates showed that QTc dispersion was the most effective predictor of ventricular tachyarrhythmia susceptibility (p < 0.001). Beta-blocker use also independently (p < 0.05) differentiated between patient groups, but maximal QTc interval, age and left ventricular ejection fraction were not JACC Vol. 26, No. 1 July 1995:174-9 PERKIOMAK1 ET AL. QT DISPERSION FOR SUSCEPTIBILITY TO VT AFTER AMI Table 3. Intraobserver and Interobserver Variability of QT Dispersion Measurement Intraobserver variability between two measurements Mean difference (ms) Relative difference (%) Interobserver variability between two observers Mean difference (ms) Relative difference (%) Healthy Subjects Pts Without VT Pts With VT 9 25 6 10 7 7 11 32 1l 18 13 13 Mean difference = mean of absolute values of measurement errors; Relative difference = mean difference relative to mean value of QT dispersion in each group. Abbreviations as in Table 1. independently associated with susceptibility to ventricular tachyarrhythmias. Accuracy of QTc dispersion in predicting susceptibility to ventricular tachyarrhythmias. When the 99% tolerance limits of normal QTe dispersion were calculated for the control group, 80 ms was obtained as the upper limit of normal QTc dispersion. When this value was used as the upper limit, QTc dispersion had a sensitivity of 70%, a specificity of 78% and a positive predictive accuracy of 70% in differentiating the postinfarction groups with and without susceptibility to ventrieular tachyarrhythmia. With the cutoff values of 70 or 100 ms, sensitivity was 77% and 53%, specificity 68% and 90% and positive predictive accuracy 64% and 80%, respectively. The absolute and relative values of intraobserver and interobserver variability of QT dispersion measurement are shown in Table 3. Discussion QT dispersion in patients with and without susceptibility to ventricular tachyarrhythmias. This cross-sectional study of patients with different susceptibilities to ventricular tachyarrhythmias shows that QT dispersion is increased in patients at risk for life-threatening arrhythmias after a previous myocardial infarction. Previous studies have shown that prolongation of the QT interval is a risk factor for ventricular arrhythmias and sudden death in patients with a previous myocardial infarction (14-18), but there has been some controversy as to the predictive accuracy of the prolonged QT interval (19-22). In the present study, the maximal QT interval was also observed to be prolonged in patients with an arrhythmic susceptibility, but QT dispersion was a more powerful predictor of susceptibility to ventricular tachyarrhythmias, suggesting that inhomogeneity of repolarization is more closely associated with arrhythmic risk than is prolongation of repolarization itself. Previous studies on the relation between QT dispersion and arrhythmic susceptibility were performed in patients with the long QT syndrome (5,10,23), hypertrophic cardiomyopathy (7,11) or congestive heart failure (24,25); in mixed patient 177 populations with ischemic heart disease (26); or in patients with torsade de pointes induced by antiarrhythmic drugs (27). In these clinical settings, the mechanisms of arrhythmogenesis have been controversial. Triggered activity due to both early afterdepolarizations and reentry have been proposed (28). However, reentry has most commonly been shown to be a mechanism of ventricular tachyarrhythmias in patients with chronic myocardial infarction (29), where dispersion in the regional recovery time may be a fundamental electrophysiologic substrate for the genesis of reentrant arrhythmias. In the present series, reentry was indeed the most probable mechanism of arrhythmia because only patients with inducible, sustained monomorphic ventricular tachycardias were included, which supports the postulation that QT interval dispersion is a sign of propensity to reentrant ventricular arrhythmias. The dispersion of QRS complex duration was similar in the two patient groups, suggesting that there are no significant differences in the dispersion of conduction in postinfarction patients with different arrhythmic susceptibilities but that changes in repolarization are most likely to be responsible for the observed QT dispersion. The broad dispersion of the total QT interval in the group with arrhythmias was mainly due to the dispersion of the Te rather than the QTa interval. This observation suggests that the regional slowing down of the terminal phase of repolarization may be important for inhomogeneities in recovery time and arrhythmogenesis. Comparison of QT dispersion between healthy subjects and patients with a previous myocardial infarction. The QT dispersion values in our healthy subjects concur with those of previous findings, demonstrating that dispersion of the QT interval in a normal heart is usually <70 ms (8,30). The patients with a previous myocardial infarction but with no ventricular tachyarrhythmia showed a somewhat increased QT dispersion compared with healthy subjects, but these dispersion values were clearly smaller than those of the patients with ventricular tachyarrhythmias. These observations confirm the assumption that chronic infarction itself creates inhomogeneities in ventricular recovery time. This inhomogeneity was not related to ejection fraction, medication or other clinical variables, suggesting that measurement of QT dispersion may yield information on the risk of ventricular tachyarrhythmias independent of degree of left ventricular dysfunction or clinical characteristics of the patient. Prediction of susceptibility to life-threatening arrhythmias. Among postinfarction patients, the identification of those at high risk for ventricular tachycardia is of great importance. The old strategies, such as evaluation of left ventricular function, ventricular ectopic activity and spontaneous arrhythmias cannot effectively identify subjects at high risk (31). The newer noninvasive methods, such as signal-averaged electrocardiography, heart rate variability and baroreceptor reflex sensitivity, offer improved risk stratification (32). However, the positive predictive accuracy of each of these methods is still limited with regard to identifying individual patients for therapeutic interventions; it is possible that the combination of these noninvasive methods may result in better accuracy (33). 178 PERKIOMAKIET At.. QT DISPERSION FOR SUSCEPTIBILITY TO VT AFTER AMI In the present series, QT dispersion had a relatively good accuracy compared with that of other noninvasive methods used in previous studies for discriminating between patients with different susceptibilities to ventricular tachyarrhythmias. Measurement of Q T dispersion is easy and inexpensive and should perhaps be included in the noninvasive evaluation of arrhythmic risk. The relative accuracy of this method, compared with others, should also be tested. However, ours was a cross-sectional study, and its results may not provide information as to the predictive accuracy of QT dispersion for future arrhythmic events but may only demonstrate that Q T dispersion is increased in patients susceptible to life-threatening arrhythmias. To estimate the predictive value of QT dispersion for arrhythmic events, a longitudinal follow-up study should be performed, but identifying tachyarrhythmic deaths or events in epidemiologic studies can be problematic. The mechanism of death attributed to ventricular arrhythmia may be bradyarrhythmia, recurrent myocardial infarction or a number of other conditions that can develop rapidly. Therefore, a crosssectional study such as the present one can provide important information on the power of different variables to predict risk for specific life-threatening arrhythmias. Study limitations. Measurements of Q T interval and its dispersion are subject to intraobservcr and interobserver variability (30,34). Kautzner et al. (30) found a notable relative interobserver error in QT dispcrsion measurements of healthy subjects (>30%). This is in accordance with our findings of interobserver variation in Q T dispersion measurements of healthy subjects in terms of relative error, but more important is the interobserver variability expressed in absolute values, which is on the order of 10 ms. Furthermore, when QT dispersion was increased, the relative interobserver and intraobserver errors became smaller. In the present study, where measurements by the same experienced observer were used for the statistical comparison of QT dispersion, the intraobserver variation within the patient groups was found to be 6 to 7 ms, which confirms that the differences in QT dispersion between the patient groups cannot be explained by measurement variability. Despite some shortcomings of Bazett's formula, it has been shown to be applicable to correction of the QT interval for heart rate in patients with myocardial infarction (35). However, it has not been used in studies to correct QTa, Te or JT intervals for heart rate. Despite that, to make these subdivisions of the QT interval and dispersion more comparable to other studies, rate correction appears to be justified. In our study, the patients with no susceptibility to ventricular tachyarrhythmia had no history, of malignant arrhythmia and no inducible ventricular tachycardia. Such patients are known to be at low risk for spontaneous ventricular tachyarrhythmias, but noninducibility during electrophysiologic testing may not provide complete predictive accuracy with regard to arrhythmia-free survival. Indeed, some patients without inducible ventricular tachycardia had a markedly increased Q T dispersion. It will be important to follow up these patients for the clinical occurrence of ventricular tachyarrhythmia. JACC Vol. 26, No. 1 July 1995:174-9 Conclusions. QT dispersion is increased in patients with a susceptibiliW for ventricular tachyarrhythmias. This indicates that variability in the length of the QT interval between the different leads of the standard 12-lead ECG is a marker for the risk of reentrant ventricular arrhythmias in patients with a previous myocardial infarction. The clinical utility of this simple, noninvasive measure should be confirmed in prospective follow-up studies in postinfarction patients. References I. Han J. De Jalon PG, Moe GK. Adrenergic effects on ventricular vulnerability. Circ Res 1964;14:516-24. 2. Han J. Moe GK. Non-uniform recovery,of excitabilityin ventricular muscle. Circ Res 1964;14:44-60. 3. Merx W, Yoon MS, Han J. The rolc of local disparity in conduction and recovery time on ventricular vulnerability to fibrillation. Am Heart J 1977;94:603-10. 4. Kuo CS, Munakata K, Rcddy CP, Surawicz B. Characteristics and possible mechanisms of ventricular arrhythmia dependent on the dispersion of action potential durations. Circulation 1983;67:1356-7. 5. Day CP, McComb JM, Campbell RWF. QT dispersion: an indication of arrhythmia risk in patients with long QT intervals.Br Heart J 1990;63:342-4. 6. Day CP, McComb JM, Campbell RWF. QT dispersion in sinus beats and ventricular extrasystolesin normal hearts. Br Heart J 1992;67:39-41. 7. Dritsas A, Gilligan D, Nichoyannopoulos P, Oakley CM. Amiodarone reduces QT dispersion in patients with hypertrophic cardiomyopathy.Int J Cardiol 1992;36:345-9. 8. Cowan JC, Yusoff K, Moore M, et al. Importance of lead selection in QT interval measurement. Am J Cardiol 1988;61:83-7. 9. Day CP, McComb JM, Manhews J, Campbell RWF. Reduction in QT dispersion by sotalol followingmyocardial infarction. Eur Heart J 1991;12: 423-7. 10. Linker NJ, Colonna P, KekwickCA, Till J, Camm AJ, Ward DE. Assessment of O1" dispersion in symptomatic patients with congenital long QT syndromes. Am J Cardiol 1992;69:634-8. 11. Buja (3, Miorelli M, Turrini P, Melacini P, Nava A. Comparison of OT dispersion in hypertrophic cardiomyopathybetween patients with and withnut ventricular arrhythmias and sudden death. Am J Cardiol 1993;72:973-6. 12. Huikuri HV, Cox M, Interian A, et al. Elficacyof intravenouspropranolol for suppression of inducibility of ventricular tachyarrhythmias with different electrophysiologiccharacteristics in coronary artery disease. Am J Cardiol 1989;64:1305 9. 13. Huikuri HV, Niemel'fiMJ, Ojala S, Rantala A, lk~heimo MJ, Airaksinen KEJ. Circadian rhythms of frequency domain measures of heart rate variability in healthy subjects and patients with coronary artery disease: effects of arousal and upright posture. Circulation 1994;90:121-6. 14. Schwartz PJ, Wolf S. QT interval prolongation as predictor of sudden death in paticnts with myocardial infarction. Circulation 1978;57:1074-7. 15. Ahnve S, Helmcrs C, Lundman T, Rehnqvist N, Sjogren A. QTc intervals in acute myocardial infarction: first-year prognostic implications. Clin Cardiol 1980;3:303-8. 16. JuuI-Moller S. Corrected QT-interval during one year follow-up after an acute myocardial infarction. Eur Heart J 1986;7:299-304. 17. Ahnve S, Gilpin E, Madsen EB, Froelicher V, Henning H, Ross J. Prognostic importance of QTc interval at discharge after acute myocardial infarction: a multicenter study of 865 patients. Am Heart J 1984;108:395-400. 18. LocatiE, Schwartz PJ. Prognostic value of QT interval prolongation in post myocardial infarction patients. Eur Heart J 1987;SupplA:121-6. 19. Wheelan K, Mukharji J, Rude RE, et al. Sudden death and its relation to QT-interval prolongation after acute myocardialinfarction: two-yearfollowup. Am J Cardiol 1986;57:745-50. 20. Pohjola-SintonenS, Siltanen P, Haapakoski J. Usefulnessof QTc interval on the discharge electrocardiogram for predicting survival after acute myocardial infarction. Am J Cardiol 1986;57:1066-8. 21. Surawicz B, Knoebel SB. Long QT: good, bad or indifferent? J Am Coil Cardiol 1984;4:398-413. JACC Vol. 26, No. 1 July 1995:174 9 22. Morganroth J. QTc inte~'al prolongation: is it beneficial or harmful? Am J Cardiol 1993;72:IB-59B. 23. Priori SG, Napolitano C, Diehl L, Schwartz PJ. Dispersion of the QT interval. A marker of therapeutic efficacy in the idiopathic long QT syndrome. Circulation 1994;89:1681-9. 24. Barr CS, Naas A, Freeman M, Lang CC, Struthers AD. QT dispersion and sudden unexpected death in chronic heart failure. Lancet 1994;343:327-9. 25. Davey PP, Bateman J, Mulligan IP, Forfar C, Barlow C, Hart G. QT interval dispersion in chronic heart failure and left ventrieular hypertrophy: relation to autonomic nervous system and Holtcr tape abnormalities. Br Heart J 1994;71:268 -73. 26. Zareba W, Moss AJ, le Cessie S. Dispersion of ventricular repolarization and arrhythmic cardiac death in coronary artery disease. Am J Cardiol 1994;74: 550-3. 27. Hii JTY, Wyse DG, Gillis AM, Duff H J, Solylo MA, Mitchell LB. Precordial QT interval dispersion as a marker of torsade de pointes. Disparate effects of class Ia antiarrhythmic drugs and amiodarone. Circulation 1992;86:137682. 28. Martins JB, Constantin L, Kienzle MG, Brownstein SL, Hopson JR. Mechanisms of ventricular tachycardia associated with coronary artery disease. In: Zipes DP, Jalife J, editors. Cardiac Electrophysiology: From Cell to Bedside. Philadelphia: Saunders, 199(1:581-8. PERKIOMAKI ET AL. OT DISPERSION FOR SUSCEPTIBILITY TO VT AFTER AMI 179 29. Josephson ME, Gottlieb CD. Ventricular tachycardia associated with coronary artery, disease. In ref. 28:571-80. 30. Kautzner J, Yi G, Carom AJ, Malik M. Short- and long-term reproducibiliW of QT, OTe, and QT dispersion measurement in healthy subjects. PACE 1994;17:928 -37. 31. Turitto G, EI-Sherif N. Complex ventricular arrhythmias and nonsustained ventricular tachycardia: risk stratification and management. In: E1-Sherif N, Samet P, editors. Cardiac Pacing and Electrophysiology. Philadelphia: Saunders, 1991:217-33. 32. Farrell TG, Bashir Y, Cripps T, et al. Risk stratification for arrhythmic events in postinfarction patients based on heart rate variability, ambulatory electrocardiographic variables and the signal averaged electrocardiogram. J Am Coil Cardiol 1991;18:687-97. 33. Bigger JT Jr, Steinberg JS. Risk stratification for arrhythmic death after myocardial infarction: an overview. In ref. 31:303-23. 34. Ahnve S. Methodological aspect of QTc interval determination. In: Butrous GS, Schwartz PJ, editors. Clinical Aspects of Ventricular Repolarization. London: Farrand Press, 1989:1-16. 35. Ahnve S. Correction of the QT interval for heart rate: review of different formulas and the use of Bazett's formula in myocardial infarction. Am Heart J 1985;109:568-74.